163 related articles for article (PubMed ID: 26152555)
1. High incidence of engraftment syndrome after haploidentical allogeneic stem cell transplantation.
Chen Y; Xu LP; Liu KY; Chen H; Chen YH; Zhang XH; Wang Y; Wang FR; Han W; Wang JZ; Yan CH; Zhang YY; Sun YQ; Huang XJ
Eur J Haematol; 2016 May; 96(5):517-26. PubMed ID: 26152555
[TBL] [Abstract][Full Text] [Related]
2. Infusion-related febrile reaction after haploidentical stem cell transplantation in children is associated with higher rates of engraftment syndrome and acute graft-versus-host disease.
Chen Y; Huang XJ; Liu KY; Chen H; Chen YH; Zhang XH; Wang FR; Han W; Wang JZ; Wang Y; Yan CH; Zhang YY; Sun YQ; Xu LP
Pediatr Transplant; 2015 Dec; 19(8):918-24. PubMed ID: 26332180
[TBL] [Abstract][Full Text] [Related]
3. HLA-haploidentical blood and bone marrow transplantation with anti-thymocyte globulin: long-term comparison with HLA-identical sibling transplantation.
Chen XH; Gao L; Zhang X; Gao L; Zhang C; Kong PY; Liu H; Peng XG; Sun AH; Qi DG; Gong Y; Wang QY
Blood Cells Mol Dis; 2009; 43(1):98-104. PubMed ID: 19356956
[TBL] [Abstract][Full Text] [Related]
4. Engraftment syndrome following allogeneic hematopoietic stem cell transplantation in children.
Nishio N; Yagasaki H; Takahashi Y; Hama A; Muramatsu H; Tanaka M; Yoshida N; Yoshimi A; Kudo K; Ito M; Kojima S
Pediatr Transplant; 2009 Nov; 13(7):831-7. PubMed ID: 19067915
[TBL] [Abstract][Full Text] [Related]
5. A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation.
Gaballa S; Palmisiano N; Alpdogan O; Carabasi M; Filicko-O'Hara J; Kasner M; Kraft WK; Leiby B; Martinez-Outschoorn U; O'Hara W; Pro B; Rudolph S; Sharma M; Wagner JL; Weiss M; Flomenberg N; Grosso D
Biol Blood Marrow Transplant; 2016 Jan; 22(1):141-8. PubMed ID: 26415558
[TBL] [Abstract][Full Text] [Related]
6. Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts.
Raiola AM; Dominietto A; di Grazia C; Lamparelli T; Gualandi F; Ibatici A; Bregante S; Van Lint MT; Varaldo R; Ghiso A; Gobbi M; Carella AM; Signori A; Galaverna F; Bacigalupo A
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1573-9. PubMed ID: 24910379
[TBL] [Abstract][Full Text] [Related]
7. Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis.
Chang YJ; Wang Y; Liu YR; Xu LP; Zhang XH; Chen H; Chen YH; Wang FR; Han W; Sun YQ; Yan CH; Tang FF; Mo XD; Liu KY; Huang XJ
J Hematol Oncol; 2017 Jul; 10(1):134. PubMed ID: 28676064
[TBL] [Abstract][Full Text] [Related]
8. The incidence, risk factors, and outcomes of primary poor graft function after unmanipulated haploidentical stem cell transplantation.
Sun YQ; He GL; Chang YJ; Xu LP; Zhang XH; Han W; Chen H; Chen YH; Wang Y; Wang FR; Wang JZ; Liu KY; Huang XJ
Ann Hematol; 2015 Oct; 94(10):1699-705. PubMed ID: 26152553
[TBL] [Abstract][Full Text] [Related]
9. Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) stem cell transplantation using nonmyeloablative conditioning.
Ogawa H; Ikegame K; Yoshihara S; Kawakami M; Fujioka T; Masuda T; Taniguchi Y; Hasei H; Kaida K; Inoue T; Kim EH; Kawase I
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1073-84. PubMed ID: 17084371
[TBL] [Abstract][Full Text] [Related]
10. Haplo-identical transplantation for acquired severe aplastic anaemia in a multicentre prospective study.
Xu LP; Wang SQ; Wu DP; Wang JM; Gao SJ; Jiang M; Wang CB; Zhang X; Liu QF; Xia LH; Wang X; Huang XJ
Br J Haematol; 2016 Oct; 175(2):265-274. PubMed ID: 27352174
[TBL] [Abstract][Full Text] [Related]
11. A novel protocol for haploidentical hematopoietic SCT without in vitro T-cell depletion in the treatment of severe acquired aplastic anemia.
Xu LP; Liu KY; Liu DH; Han W; Chen H; Chen YH; Zhang XH; Wang Y; Wang FR; Wang JZ; Huang XJ
Bone Marrow Transplant; 2012 Dec; 47(12):1507-12. PubMed ID: 22635243
[TBL] [Abstract][Full Text] [Related]
12. Superior graft-versus-leukemia effect associated with transplantation of haploidentical compared with HLA-identical sibling donor grafts for high-risk acute leukemia: an historic comparison.
Wang Y; Liu DH; Xu LP; Liu KY; Chen H; Chen YH; Han W; Shi HX; Huang XJ
Biol Blood Marrow Transplant; 2011 Jun; 17(6):821-30. PubMed ID: 20831895
[TBL] [Abstract][Full Text] [Related]
13. Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignancies.
Ostronoff F; Ostronoff M; Souto-Maior AP; Domingues M; Sucupira A; Manso DA; de Lima AK; Monteiro PG; Florêncio R; Calixto R
Clin Transplant; 2009; 23(1):33-8. PubMed ID: 18727660
[TBL] [Abstract][Full Text] [Related]
14. Comparison of outcomes in hematological malignancies treated with haploidentical or HLA-identical sibling hematopoietic stem cell transplantation following myeloablative conditioning: A meta-analysis.
Chen D; Zhou D; Guo D; Xu P; Chen B
PLoS One; 2018; 13(1):e0191955. PubMed ID: 29381772
[TBL] [Abstract][Full Text] [Related]
15. Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center.
Carreras E; Fernández-Avilés F; Silva L; Guerrero M; Fernández de Larrea C; Martínez C; Rosiñol L; Lozano M; Marín P; Rovira M
Bone Marrow Transplant; 2010 Sep; 45(9):1417-22. PubMed ID: 20062097
[TBL] [Abstract][Full Text] [Related]
16. Stem-cell transplantation in children with acute lymphoblastic leukemia: A prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003 trial.
Peters C; Schrappe M; von Stackelberg A; Schrauder A; Bader P; Ebell W; Lang P; Sykora KW; Schrum J; Kremens B; Ehlert K; Albert MH; Meisel R; Matthes-Martin S; Gungor T; Holter W; Strahm B; Gruhn B; Schulz A; Woessmann W; Poetschger U; Zimmermann M; Klingebiel T
J Clin Oncol; 2015 Apr; 33(11):1265-74. PubMed ID: 25753432
[TBL] [Abstract][Full Text] [Related]
17. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
[TBL] [Abstract][Full Text] [Related]
18. Related HLA-mismatched/haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: observations of a single Chinese center.
Huang X; Liu D
Clin Transpl; 2011; ():237-45. PubMed ID: 22755417
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of haploidentical transplant compared with matched donor allogeneic stem cell transplant.
Adhikari J; Gyawali B; Sharma P; Bhatt VR
Future Oncol; 2017 Apr; 13(10):935-944. PubMed ID: 27935324
[TBL] [Abstract][Full Text] [Related]
20. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
